항-TIM-3 항체 및 조성물

본 발명은 항-TIM-3 항체 및 항체 조성물 및 환자에서 면역성을 향상시키는, 예를 들어, 암을 치료하기 위한 이들의 용도에 관한 것이다. This invention relates to anti-TIM-3 antibodies and antibody compositions and their use in enhancing immunity in a patient, e.g., to treat cancer....

Full description

Saved in:
Bibliographic Details
Main Authors KOEFOED KLAUS, BOUQUIN THOMAS, LINDSTED TRINE, GAD MONIKA, GRANDAL MICHAEL MONRAD, PEDERSEN MIKKEL WANDAHL, GJETTING TORBEN, HORAK IVAN DAVID, KRAGH MICHAEL, GALLER GUNTHER ROLAND
Format Patent
LanguageKorean
Published 14.12.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract 본 발명은 항-TIM-3 항체 및 항체 조성물 및 환자에서 면역성을 향상시키는, 예를 들어, 암을 치료하기 위한 이들의 용도에 관한 것이다. This invention relates to anti-TIM-3 antibodies and antibody compositions and their use in enhancing immunity in a patient, e.g., to treat cancer.
AbstractList 본 발명은 항-TIM-3 항체 및 항체 조성물 및 환자에서 면역성을 향상시키는, 예를 들어, 암을 치료하기 위한 이들의 용도에 관한 것이다. This invention relates to anti-TIM-3 antibodies and antibody compositions and their use in enhancing immunity in a patient, e.g., to treat cancer.
Author GALLER GUNTHER ROLAND
GAD MONIKA
BOUQUIN THOMAS
KOEFOED KLAUS
KRAGH MICHAEL
LINDSTED TRINE
GRANDAL MICHAEL MONRAD
GJETTING TORBEN
HORAK IVAN DAVID
PEDERSEN MIKKEL WANDAHL
Author_xml – fullname: KOEFOED KLAUS
– fullname: BOUQUIN THOMAS
– fullname: LINDSTED TRINE
– fullname: GAD MONIKA
– fullname: GRANDAL MICHAEL MONRAD
– fullname: PEDERSEN MIKKEL WANDAHL
– fullname: GJETTING TORBEN
– fullname: HORAK IVAN DAVID
– fullname: KRAGH MICHAEL
– fullname: GALLER GUNTHER ROLAND
BookMark eNrjYmDJy89L5WSQezt1rW6Ip6-usQKQ9WbTFoXXG_oV3izc8KZl4-s1e3gYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSbx3kJGBoYWBobGxiYWRozFxqgDKfS0B
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20180133482A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20180133482A3
IEDL.DBID EVB
IngestDate Fri Jul 19 12:56:56 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20180133482A3
Notes Application Number: KR20187032586
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181214&DB=EPODOC&CC=KR&NR=20180133482A
ParticipantIDs epo_espacenet_KR20180133482A
PublicationCentury 2000
PublicationDate 20181214
PublicationDateYYYYMMDD 2018-12-14
PublicationDate_xml – month: 12
  year: 2018
  text: 20181214
  day: 14
PublicationDecade 2010
PublicationYear 2018
RelatedCompanies SYMPHOGEN A
RelatedCompanies_xml – name: SYMPHOGEN A
Score 3.1380832
Snippet 본 발명은 항-TIM-3 항체 및 항체 조성물 및 환자에서 면역성을 향상시키는, 예를 들어, 암을 치료하기 위한 이들의 용도에 관한 것이다. This invention relates to anti-TIM-3 antibodies and antibody compositions and...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title 항-TIM-3 항체 및 조성물
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181214&DB=EPODOC&locale=&CC=KR&NR=20180133482A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSUwyNDKwMLfUTTUyT9M1Ac0eJhklm-iaJlmaJBlZpBlCpmJ8_cw8Qk28IkwjmBhyYHthwOeEloMPRwTmqGRgfi8Bl9cFiEEsF_DaymL9pEygUL69W4itixq0dwyqrgxN1FycbF0D_F38ndWcnW29g9T8gsBywNYO6CgXR2YGVmBD2hyUH1zDnED7UgqQKxU3QQa2AKB5eSVCDEzZ-cIMnM6wu9eEGTh8oVPeQCY09xWLMMi9nbpWN8TTV9dYAch6s2mLwusN_QpvFm5407Lx9Zo9ogzKbq4hzh66QIvi4f6K9w5CdpWxGAMLsMefKsGgYGBsCswmKclGiUnGJolmZokGxmmWwJYVsCo3s0gxMpVkkMFnkhR-aWkGLhAXtCbD0ESGgaWkqDRVFlizliTJgQMEAACWf4Q
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSUwyNDKwMLfUTTUyT9M1Ac0eJhklm-iaJlmaJBlZpBlCpmJ8_cw8Qk28IkwjmBhyYHthwOeEloMPRwTmqGRgfi8Bl9cFiEEsF_DaymL9pEygUL69W4itixq0dwyqrgxN1FycbF0D_F38ndWcnW29g9T8gsBywNYO6CgXR2YGVmAj2xyUH1zDnED7UgqQKxU3QQa2AKB5eSVCDEzZ-cIMnM6wu9eEGTh8oVPeQCY09xWLMMi9nbpWN8TTV9dYAch6s2mLwusN_QpvFm5407Lx9Zo9ogzKbq4hzh66QIvi4f6K9w5CdpWxGAMLsMefKsGgYGBsCswmKclGiUnGJolmZokGxmmWwJYVsCo3s0gxMpVkkMFnkhR-aXkGTo8QX594H08_b2kGLpAUaH2GoYkMA0tJUWmqLLCWLUmSAwcOACYjgnc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=%ED%95%AD-TIM-3+%ED%95%AD%EC%B2%B4+%EB%B0%8F+%EC%A1%B0%EC%84%B1%EB%AC%BC&rft.inventor=KOEFOED+KLAUS&rft.inventor=BOUQUIN+THOMAS&rft.inventor=LINDSTED+TRINE&rft.inventor=GAD+MONIKA&rft.inventor=GRANDAL+MICHAEL+MONRAD&rft.inventor=PEDERSEN+MIKKEL+WANDAHL&rft.inventor=GJETTING+TORBEN&rft.inventor=HORAK+IVAN+DAVID&rft.inventor=KRAGH+MICHAEL&rft.inventor=GALLER+GUNTHER+ROLAND&rft.date=2018-12-14&rft.externalDBID=A&rft.externalDocID=KR20180133482A